616 filings
Page 6 of 31
S-8
ENTO
Entero Therapeutics Inc.
4 Apr 23
Registration of securities for employees
5:28pm
S-8
ENTO
Entero Therapeutics Inc.
4 Apr 23
Registration of securities for employees
5:27pm
EFFECT
ENTO
Entero Therapeutics Inc.
28 Mar 23
Notice of effectiveness
12:15am
424B3
ENTO
Entero Therapeutics Inc.
27 Mar 23
Prospectus supplement
4:31pm
D
ENTO
Entero Therapeutics Inc.
23 Mar 23
$4.00 mm in equity / options, sold $4.00 mm, 1 investor
5:00pm
UPLOAD
ENTO
Entero Therapeutics Inc.
23 Mar 23
Letter from SEC
12:00am
CORRESP
ENTO
Entero Therapeutics Inc.
23 Mar 23
Correspondence with SEC
12:00am
S-3
ENTO
Entero Therapeutics Inc.
Shelf registration
21 Mar 23
4:38pm
10-K
2022 FY
ENTO
Entero Therapeutics Inc.
Annual report
20 Mar 23
4:10pm
8-K
ENTO
Entero Therapeutics Inc.
15 Mar 23
First Wave BioPharma Announces $4.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
11:13am
SC 13G
ENTO
Entero Therapeutics Inc.
14 Feb 23
First Wave BioPharma / ARMISTICE CAPITAL ownership change
12:43pm
8-K
ENTO
Entero Therapeutics Inc.
7 Feb 23
Regulation FD Disclosure
7:43am
8-K
ENTO
Entero Therapeutics Inc.
17 Jan 23
First Wave BioPharma Announces Results of Special Meeting of Stockholders
9:15am
DEFA14A
ENTO
Entero Therapeutics Inc.
9 Jan 23
Additional proxy soliciting materials
9:22am
4
Mary Theresa Coelho
5 Jan 23
First Wave BioPharma / Mary Theresa Coelho ownership change
9:02am
4
ENTO
Entero Therapeutics Inc.
5 Jan 23
First Wave BioPharma / Sarah Romano ownership change
9:01am
4
Sapirstein James
5 Jan 23
First Wave BioPharma / JAMES SAPIRSTEIN ownership change
9:00am
4
ENTO
Entero Therapeutics Inc.
5 Jan 23
First Wave BioPharma / EDWARD BORKOWSKI ownership change
8:58am
4
David Andrew Hoffman
5 Jan 23
First Wave BioPharma / David Andrew Hoffman ownership change
8:56am
4
ENTO
Entero Therapeutics Inc.
5 Jan 23
First Wave BioPharma / CHARLES J CASAMENTO ownership change
8:55am